Aceto reported -13310000 in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acasti Pharma ACST:US C$ -3.57M 1.27M
Aceto ACET:US -13310000 3.68M
Agile Therapeutics AGRX:US $ -15.22M 0.88M
Glaxosmithkline GSK:US $ 3660M 1034M
Idera Pharmaceuticals IDRA:US $ -5.83M 0.53M
Novartis NVS:US $ 4837M 65M
Pain Therapeutics PTIE:US $ -9.54M 4.41M
Pfizer PFE:US $ 10235M 2245M
Prestige Brands PBH:US $ 86.52M 12.42M